A Pilot Study of Abiraterone Acetate in African American/Black Patients With Castration Resistant Prostate Cancer
Phase of Trial: Phase II
Latest Information Update: 16 May 2017
At a glance
- Drugs Abiraterone acetate (Primary) ; Prednisone
- Indications Adenocarcinoma; Prostate cancer
- Focus Pharmacogenomic; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 09 Jan 2017 Status changed from active, no longer recruiting to discontinued.
- 10 Jul 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.